1. Main page
  2. Biotechnology
  3. Debiopharm Group

Debiopharm Group

12 Decision Makers · 18 Verified Contacts & Email Format

debiopharm.com
📍 Lausanne, Vaud, SwitzerlandBiotechnology🗓 Est. 1979👥 501–1000 employees 💰 $50M–$100M

About Debiopharm Group

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.

Email Format

{first_name}.{last_name}@debiopharm.com — 100.0%

sarah.smith@debiopharm.com

Leadership & Decision Makers

Contact details of 12 Debiopharm Group decision makers

Thierry Mauvernay

President & Delegate of the Board

Sophie Genecand

Director, Real Estate department, Debiopharm Investment S.A.

ANGELA ZUBEL

Chief Development Officer

Bertrand Ducrey

CEO

Raymond Zaugg

Director, Financial department, Debiopharm Investment S.A

Alexandra Le Coz Sanchez

Associate Director, Private Equity Department, Debiopharm Investment S.A.

Rolland-Yves Mauvernay

Founder

Hervé Porchet

Vice-President

Pierre JULLIAN

CFO

Gilbert Merminod Ferrari

Managing Director

Marc Cikes

Managing Director

Cédric Sager

CEO

Team & Specialists

Contact details of 6 Debiopharm Group team members

Patrick Garrouste

  • Work email

    p***************e@debiopharm.com

Valerie Blasco

  • Work email

    v************o@debiopharm.com

Claire Laprun

  • Work email

    c***********n@debiopharm.com

dawn Bonine

  • Work email

    d**************e@debiopharm.com

David Cameron

  • Work email

    d***********n@debiopharm.com

Riccardo Nisato

Licensing and Grants Associate Manager

General Emails

General company emails, e.g. customer support lines

    communication@debiopharm.com

    Unclassified inbox

    mwagner@debiopharm.com

    Unclassified inbox

    mmurone@debiopharm.com

    Unclassified inbox

    mbarbier@debiopharm.com

    Unclassified inbox

Verify Debiopharm Group Emails

Similar Companies like Debiopharm Group

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Vertex Pharmaceuticals

vrtx.com
Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 14/07/2025

debiopharm.com

+41213210111

Lausanne, Vaud, Switzerland

Business Type: Private
Employees: 501-1000
Annual Revenue: $50M–$100M
Rounds: Grant
Founded Date: 1979
Number of Exits: 6
Company Type: For Profit
Operating Status: Active
Last Funding Type: Grant
Phone Number: +41213210111
Last Investment Activity: Sep 28, 2023
Investments Activity: Sep 28, 2023 Sep 12, 2022 Oct 19, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.